BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 103 filers reported holding BIOSCRIP INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $205,000 | -42.4% | 75,646 | -63.9% | 0.01% | -40.0% |
| Q1 2017 | $356,000 | +350.6% | 209,586 | +176.2% | 0.01% | +400.0% |
| Q4 2016 | $79,000 | +139.4% | 75,871 | +569.4% | 0.00% | +100.0% |
| Q3 2016 | $33,000 | -86.7% | 11,334 | -88.3% | 0.00% | -80.0% |
| Q2 2016 | $248,000 | +113.8% | 97,092 | +79.4% | 0.01% | +66.7% |
| Q1 2016 | $116,000 | -29.3% | 54,120 | -42.4% | 0.00% | 0.0% |
| Q4 2015 | $164,000 | +272.7% | 93,911 | +302.4% | 0.00% | +200.0% |
| Q3 2015 | $44,000 | -79.0% | 23,336 | -23.1% | 0.00% | -75.0% |
| Q3 2014 | $210,000 | +52.2% | 30,362 | +83.2% | 0.00% | +100.0% |
| Q2 2014 | $138,000 | +89.0% | 16,577 | +57.3% | 0.00% | +100.0% |
| Q1 2014 | $73,000 | -24.7% | 10,541 | -20.0% | 0.00% | 0.0% |
| Q4 2013 | $97,000 | -83.9% | 13,183 | -80.8% | 0.00% | -87.5% |
| Q3 2013 | $602,000 | – | 68,598 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coliseum Capital Management, LLC | 5,622,410 | $5,847,000 | 2.64% |
| NORTH TIDE CAPITAL, LLC | 8,500,000 | $8,840,000 | 1.51% |
| WYNNEFIELD CAPITAL INC | 3,700,000 | $3,848,000 | 1.39% |
| Alta Fundamental Advisers LLC | 2,330,774 | $2,424,000 | 1.20% |
| ARDSLEY ADVISORY PARTNERS LP | 6,350,000 | $6,604,000 | 1.09% |
| Camber Capital Management LP | 10,180,000 | $10,587,000 | 0.55% |
| PERKINS CAPITAL MANAGEMENT INC | 298,000 | $310,000 | 0.34% |
| Hawk Ridge Capital Management | 340,429 | $354,000 | 0.18% |
| Eidelman Virant Capital | 220,000 | $228,000 | 0.13% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 227,280 | $236,000 | 0.11% |